These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

123 related items for PubMed ID: 15596197

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. The role of FDG PET in management of neck metastasis from head-and-neck cancer after definitive radiation treatment.
    Yao M, Smith RB, Graham MM, Hoffman HT, Tan H, Funk GF, Graham SM, Chang K, Dornfeld KJ, Menda Y, Buatti JM.
    Int J Radiat Oncol Biol Phys; 2005 Nov 15; 63(4):991-9. PubMed ID: 16099601
    [Abstract] [Full Text] [Related]

  • 23. Germ cell tumor: differentiation of viable tumor, mature teratoma, and necrotic tissue with FDG PET and kinetic modeling.
    Sugawara Y, Zasadny KR, Grossman HB, Francis IR, Clarke MF, Wahl RL.
    Radiology; 1999 Apr 15; 211(1):249-56. PubMed ID: 10189480
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. The role of [(18)F] FDG-PET, CT/MRI and tumor marker kinetics in the evaluation of post chemotherapy residual masses in metastatic germ cell tumors--prospects for management.
    Pfannenberg AC, Oechsle K, Bokemeyer C, Kollmannsberger C, Dohmen BM, Bares R, Hartmann JT, Vonthein R, Claussen CD.
    World J Urol; 2004 Jun 15; 22(2):132-9. PubMed ID: 14735310
    [Abstract] [Full Text] [Related]

  • 27. The GETUG SEMITEP Trial: De-escalating Chemotherapy in Good-prognosis Seminoma Based on Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography.
    Loriot Y, Texier M, Culine S, Fléchon A, Thiery-Vuillemin A, Gravis G, Geoffrois L, Chevreau C, Gross-Goupil M, Barthelemy P, Bompas E, Mahammedi H, Laguerre B, Lacourtoisie SA, Helissey C, Ladoire S, Abraham C, Massard C, Grimaldi S, Fizazi K.
    Eur Urol; 2022 Aug 15; 82(2):172-179. PubMed ID: 35599187
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Prognostic value of PET using 18F-FDG in Hodgkin's disease for posttreatment evaluation.
    Guay C, Lépine M, Verreault J, Bénard F.
    J Nucl Med; 2003 Aug 15; 44(8):1225-31. PubMed ID: 12902411
    [Abstract] [Full Text] [Related]

  • 31. [F-18]fluorodeoxyglucose positron emission tomography and positron emission tomography: computed tomography in recurrent and metastatic cholangiocarcinoma.
    Jadvar H, Henderson RW, Conti PS.
    J Comput Assist Tomogr; 2007 Aug 15; 31(2):223-8. PubMed ID: 17414758
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. [Value of 18F-FDG PET imaging in diagnosing tumor residue of intracranial glioma after surgery and radiotherapy].
    Chen YR, Li WX, Lin YR, Chen LH.
    Ai Zheng; 2004 Oct 15; 23(10):1210-2. PubMed ID: 15473938
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Clinical outcomes of patients with nonseminomatous germ cell tumours and negative postchemotherapy positron emission tomography.
    Buchler T, Simonova K, Fencl P, Jarkovsky J, Abrahamova J.
    Cancer Invest; 2012 Jul 15; 30(6):487-92. PubMed ID: 22506657
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. PET imaging in the management of tumors of testis and ovary: current thinking and future directions.
    Basu S, Rubello D.
    Minerva Endocrinol; 2008 Sep 15; 33(3):229-56. PubMed ID: 18846028
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.